- Country: Russia
- Summary: Supply of a Medicinal Product for Medical Use (Inn Infliximab, Tn Remicade) to Provide the Patient with the Decision of the Vii Medical Commission (Registration Number...
- RUT Ref No: 89372484
- Deadline: 28 Sep 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 133742.22
- Notice Type: Tender
- Document Ref. No.: 0352300004123000157
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Supply of a medicinal product for medical use (INN Infliximab, TN Remicade) to provide the patient with the decision of the VII medical commission (Registration number 2023.062376)
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of a Medicinal Product for Medical Use (Inn Infliximab, Tn Remicade) to Provide the Patient with the Decision of the Vii Medical Commission (Registration Number... - Russia Tender
The BUDGETARY HEALTH INSTITUTION OF THE OMSK REGION "CITY CHILDREN'S CLINICAL HOSPITAL NO. 3, a Government sector organization in Russia, has announced a new tender for Supply of a Medicinal Product for Medical Use (Inn Infliximab, Tn Remicade) to Provide the Patient with the Decision of the Vii Medical Commission (Registration Number.... This tender is published on RussiaTenders under RUT Ref No: 89372484 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-09-28.
The estimated tender value is RUB 133742.22, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
